Last update:

Weight management news

Britain's quarter century: Experts in sex, mental health, nutrition and addiction assess nation's changing well-being

A good way to follow the health of a nation is to glance at what is known as period life expectancy. This calculates how long a person born today would live if the current death rates remained exactly the same for the rest ...

New obesity definitions reveal ill health more accurately than body mass index

Traditionally, obesity has been classified primarily using BMI, a measure of weight relative to height that provides limited information about whether excess fat is actually affecting a person's health. BMI levels have historically ...

Unexpected brain mechanism challenges assumptions about GLP-1s

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, ...

FDA approves higher-dose Wegovy to help people lose more weight

A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose. The U.S. Food and Drug Administration (FDA) approved a 7.2-milligram dose of Novo Nordisk's semaglutide, ...

What to know about fatty liver disease and why it's so common

Fatty liver disease is when too much fat builds up in the liver. The liver is the body's filter. It helps clean the blood, store energy and process nutrients. If too much fat stays in the liver, it can harm the organ and ...

Testosterone improves fat distribution for older women

As we age, the amount and distribution of fat in our bodies changes. Most fat is subcutaneous—meaning it is stored just under the skin. Subcutaneous fat generally does not have detrimental health impacts. In fact, we need ...

India to tackle global obesity with cheap fat-loss jabs

A deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent expired Friday.

Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

Research finds links among work, diet and chronic illnesses

Two related studies published recently by international teams—including researchers with the UCLA Fielding School of Public Health and the UCLA Joe C. Wen School of Nursing—examined how diabetes, heart disease and other chronic ...

Recommendations developed for faltering weight in children

In a clinical practice guideline issued by the American Academy of Pediatrics, in partnership with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, recommendations are presented for the ...